Metraipolis › archive › dc_a08cf37bc0dc

Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases — Europe PMC PMID:41952778

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41952778
DOI
10.1016/j.conctc.2026.101633
License (as archived)
solo-consultazione
Archived
2026-10-07T19:01:34.383Z
SHA-256 of the archived text
e3cb6d03a87c56f764cb8d94146129cceb37c1bf6a9c6f0de70be98ca5aa7639
Stable URL of this page
https://metraipolis.com/documento/dc_a08cf37bc0dc

How to cite

Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases — Europe PMC PMID:41952778 — Europe PMC (en), https://europepmc.org/article/MED/41952778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a08cf37bc0dc (Metraipolis archive dc_a08cf37bc0dc, sha256 e3cb6d03a87c56f764cb8d94146129cceb37c1bf6a9c6f0de70be98ca5aa7639)
BibTeX
@misc{dca08cf37bc0dc,
  title = {Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases — Europe PMC PMID:41952778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41952778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a08cf37bc0dc; sha256 e3cb6d03a87c56f764cb8d94146129cceb37c1bf6a9c6f0de70be98ca5aa7639},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41952778. Agents can read the archived copy with the MCP tool read_document.